These above-reported pieces of evidence of pharmacodynamic action of HSSD in treating influenza are mainly related to the inhibition of protein target NA required for early viral infection or the inhibition of inflammatory response caused by viral infection including TLR4/MyD88, NF-κB, and MAPKs pathways. This evidence concerns the gene NFKB1 and influenza.